Is Ocrelizumab in shortage right now?

No. FDA does not currently list Ocrelizumab in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Ocrelizumab?

2 companies have marketed Ocrelizumab in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

Market view

ocrelizumab · Injection

1 marketed package NDCs · 1 active manufacturer

All forms Liquid (3)Injection (1)

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

Same drug class

Other molecules FDA puts in CD20-directed Cytolytic Antibody, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Ocrelizumab in shortage right now?: No. FDA does not currently list Ocrelizumab in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Ocrelizumab?: 2 companies have marketed Ocrelizumab in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.